"Cost-effectiveness analysis of sorafenib for the treatment of advanced hematocellular carcinoma from the perspective of the Brazilian Unified Health System (SUS)" (Professional Master's Degree). Candidate: Rafael Luis Moura Lima do Carmo. Advisor: professor André Deeke Sasse. October 30, 2019, at 9:30 am, in the FCM Postgraduate amphitheater.
Cost-effectiveness analysis of sorafenib for the treatment of advanced hematocellular carcinoma from the perspective of the Brazilian Unified Health System (SUS)
